Mechanistically, TRIM17 regulates FTO degradation via ubiquitination, modulates PDK1 gene methylation, and thereby activates the AKT/mTOR signaling pathway, promoting osteosarcoma malignancy. Here, MTOR is linked to osteosarcoma.